Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5629]

Researchers crack gastric cancer’s ‘metabolic code’: Tumour growth slowed by 65%, plus a 6.3-fold kill rate with cholesterol inhibitors in neuron-infiltrated cases

Researchers crack gastric cancer’s ‘metabolic code’: Tumour growth slowed by 65%, plus a 6.3-fold kill rate with...

Lower doses of immunotherapy for skin cancer give better results

Lower doses of immunotherapy for skin cancer give better results

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: Study suggests that a virtual programme focusing on diet and exercise can help reduce side effects of lymphoma treatment

ASH 2025: Study suggests that a virtual programme focusing on diet and exercise can help reduce side effects of...

From lab to clinic: Phase 1 clinical trial of promising combination therapy for resistant ovarian cancer

From lab to clinic: Phase 1 clinical trial of promising combination therapy for resistant ovarian cancer

Pathway discovered to make the most common breast cancer tumour responsive to immunotherapy

Pathway discovered to make the most common breast cancer tumour responsive to immunotherapy

Identifying genes that keep cancer from spreading

Identifying genes that keep cancer from spreading

MYC targeting by omomyc synergizes with PARP inhibition and potentiates antitumour response in preclinical models of triple-negative breast cancer

MYC targeting by omomyc synergizes with PARP inhibition and potentiates antitumour response in preclinical models...

Researchers suppresses side effects of mRNA therapeutics, broadly applicable platform for safer, personalised treatments

Researchers suppresses side effects of mRNA therapeutics, broadly applicable platform for safer, personalised...

An overlooked hormone eyed as deadly driver of postmenopausal breast cancer in women with obesity

An overlooked hormone eyed as deadly driver of postmenopausal breast cancer in women with obesity

More from ecancer